Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Stuschke, Martin; Poettgen, Christoph; Gauler, Thomas et al.
Long-term Survival and competing Risks of Patients in a randomized Trial of definitive vs. neoadjuvant Chemoradiation plus Resection with post-induction resectable Stage III NSCLCSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 199. 2023 S. S7-S8
Decker, Thomas; Ludtke-Heckenkamp, Kerstin; Melnichuk, Luidmila et al.
Maintenance Therapy with ET and Ribociclib after 1st line Chemotherapy (CT) in Hormone Receptor (HR)-positive/HER2-negative Metastatic Breast Cancer (BC): a Phase II Trial (AMICA)CANCER RESEARCH. Bd. 83. H. 5. 2023
Rausch, Johanna; Dzama, Margarita M.; Dolgikh, Nadezda et al.
Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclaxHAEMATOLOGICA. Bd. 108. H. 10. 2023 S. 2837-2843
Depenbusch, J.; Sweegers, M. G.; Aaronson, N. K. et al.
Metastatic breast cancer patients' perspectives on exercise programs: A qualitative evaluation in four European countriesONCOLOGY RESEARCH AND TREATMENT. Bd. 46. H. SUPPL 3. 2023
Weide, R.; Feiten, S.; Wassmann, C. et al.
Metastatic breast cancer: survival improvement in routine care 1995-2022ONCOLOGY RESEARCH AND TREATMENT. Bd. 46. 2023 S. 28-28
Kriegsmann, Katharina; Bittrich, Max; Sauer, Sandra et al.
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB StudyTRANSFUSION MEDICINE AND HEMOTHERAPY. Bd. 50. H. 5. 2023 S. 403-416
Haber, Philipp K.; Castet, Florian; Torres-Martin, Miguel et al.
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular CarcinomaGASTROENTEROLOGY. Bd. 164. H. 1. 2023
Greco, Raffaella; Hoogenboom, Jorinde D.; Bonneville, Edouard F. et al.
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working PartyBONE MARROW TRANSPLANTATION. 2023
Harbeck, Nadia; Wrobel, Denise; Zaiss, Matthias et al.
Neratinib as extended adjuvant treatment of HER2-positive/HR-positive early breast cancer patients in Germany, Austria and Switzerland: interim results of the prospective, observational ELEANOR studyBREAST CARE. 2023
Ugurel, Selma; Schmidberger, Heinz
New trends in melanoma From adjuvant therapy in stage II to novel treatment strategies with ImmTACsONKOLOGIE. Bd. 29. H. 8. 2023 S. 656-659